Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.48 |
| ▸ | MAOB | P27338 | 4/20 | 0.48 |
| ▸ | CDC25B | P30305 | 3/20 | 0.48 |
| ▸ | IDO1 | P14902 | 3/20 | 0.48 |
| ▸ | SNCA | P37840 | 2/20 | 0.48 |
| ▸ | AKT1 | P31749 | 1/20 | 0.48 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.48 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.48 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.48 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.48 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | S100A4 | P26447 | 4/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.38 |
| ▸ | BCHE | P06276 | 2/20 | 0.38 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20366857 | 0.76 | CDC25B (0.56) | MAOAMAOBCDC25BIDO1SNCA | |
| SCHEMBL1450360 | 0.75 | MEN1 (0.39) | MAOAMAOBCDC25BIDO1SNCA | |
| SCHEMBL57446 | 0.75 | MAOA (0.46) | MAOAMAOBCDC25BIDO1SNCA | |
| SCHEMBL9768584 | 0.70 | CA1 (0.42) | CDC25BIDO1PIN1MEN1KMT2A | |
| SCHEMBL855431 | 0.69 | MAOA (0.56) | MAOAMAOBCDC25BIDO1SNCA | |
| SCHEMBL29385474 | 0.69 | MAOA (0.56) | MAOAMAOBCDC25BIDO1SNCA | |
| SCHEMBL88188 | 0.69 | CES1 (0.52) | MAOAMAOBCDC25BIDO1SNCA | |
| SCHEMBL29353628 | 0.69 | CES1 (0.52) | MAOAMAOBCDC25BIDO1SNCA | |
| SCHEMBL28905016 | 0.68 | PTPRC (0.45) | MAOAMAOBCDC25BIDO1SNCA | |
| Water SCHEMBL460840 | 0.67 | MAOA (0.54) | MAOAMAOBCDC25BIDO1SNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106456824-A | Heterogeneous block comprising foam | 宝洁公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106456825-A | Heterogeneous block comprising foam | 宝洁公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-104040385-A | Retardation film, method for producing retardation film, polarizing plate, and liquid crystal display device | KONICA MINOLTA INC | 2014-09-10 | — | — | CN | disclosed |
| CN-103975260-A | Polarizing plate and liquid crystal display device | KONICA MINOLTA INC | 2014-08-06 | — | — | CN | disclosed |
| CN-103518151-A | Retardation film, polarizing plate, liquid crystal display device, and compound | KONICA MINOLTA ADVANCED LAYERS | 2014-01-15 | — | — | CN | disclosed |
| CN-103314315-A | Optical film, and polarizing plate and liquid crystal display device using same | KONICA MINOLTA OPTO INC | 2013-09-18 | — | — | CN | disclosed |
| CN-103064143-A | Optical compensation film, method for producing same, polarizing plate, and liquid crystal display device | KONICA MINOLTA OPTO INC | 2013-04-24 | — | — | CN | disclosed |
| CN-1841092-B | Optical film | KONICA MINOLTA OPTO INC | 2012-11-28 | — | — | CN | disclosed |
| US-8293341-B2 | Cellulose ester film, retardation film, polarizing plate and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| CN-101939673-B | Retardation film | KONICA MINOLTA OPTO INC | 2012-08-08 | — | — | CN | disclosed |
| US-7005440-B1 | Therapeutic uses of tri-aryl acid derivatives | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2006-02-28 | — | — | US | disclosed |
| CN-1619344-A | Polarizing plate and display device | KONICA MINOLTA OPTO INC (JP) | 2005-05-25 | — | — | CN | disclosed |
| US-20030220373-A1 | Therapeutic uses of PPAR mediators | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2003-11-27 | — | — | US | disclosed |
| US-6635655-B1 | Agonists or antagonists of peroxisome proliferator-activated receptors | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-10-21 | — | — | US | disclosed |
| EP-1267874-A2 | THERAPEUTIC USES OF PPAR MEDIATORS | Aventis Pharma Deutschland GmbH (DE) | 2003-01-02 | — | — | EP | disclosed |
| EP-1177176-A1 | TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | Aventis Pharma Deutschland GmbH (DE) | 2002-02-06 | — | — | EP | disclosed |
| EP-1177187-A1 | DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | Aventis Pharma Deutschland GmbH (DE) | 2002-02-06 | — | — | EP | disclosed |
| WO-2001066098-A2 | THERAPEUTIC USES OF PPAR MEDIATORS | AVENTIS PHARMA DEUTSCHLAND GMBH | 2001-09-13 | — | — | WO | disclosed |
| WO-2000064888-A1 | DI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-11-02 | — | — | WO | disclosed |
| WO-2000064876-A1 | TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220373-A1 | Therapeutic uses of PPAR mediators | PPARG, PPARA, PPARD | MAOA 4510/4885MAOB 4292/4885CDC25B 4270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.